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Article
Introduction
Cancer is the leading cause of death in Canada, accounting 
for approximately 30% of all mortalities.1 Along with 
increasing cancer incidence and prevalence in Canada,2 sur-
vival rates are increasing due to enhanced screening and 
better treatment.3 This has resulted in a large cohort of peo-
ple termed “cancer survivors.”4 To enhance quality of life 
and cope with treatment toxicities, many cancer survivors 
look beyond conventional medicine and are turning to com-
plementary and alternative medicine (CAM).5
CAM is defined by the National Center for Complementary 
and Integrative Health (NCCIH) as “a group of diverse medi-
cal and health care systems, practices, and products that are 
not generally considered part of conventional medicine.”6 
CAM is a broad umbrella term for several categories 
including natural health products, mind–body medicine, 
manipulative and body-based practices, energy therapy, and 
whole medical systems (eg, naturopathy).6 It includes both 
complementary and alternative therapies, 2 distinct forms of 
treatment. Complementary therapies (CTs) are used in 
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Abstract
Background. Complementary therapies (CTs) are increasingly utilized by cancer patients. Nonetheless, patients report 
insufficient support from health care practitioners (HCPs) and there is a general lack of patient-practitioner communication 
about CT use. Best care practices suggest that HCPs should address the needs of patients, including CT use. This study 
examined current practices of patients and HCPs as well as their interactions relating to CTs. Methods. A total of 481 
cancer outpatients and 100 HCPs completed questionnaires. Patient questions addressed CT use and information needs; 
HCP questions addressed knowledge, opinions and beliefs about complementary and alternative medicine. Patient-
practitioner communication around CT was also examined. Results. 47% of patients reported using CTs since diagnosis. 
Many commenced CT use to improve quality of life (65%) based on recommendations from family or friends. Patients 
acknowledged the need for trusted sources of information and would attend a hospital-based education program (72%). 
HCPs reported limited training about CTs but most (90%) expressed interested in receiving more training. The majority of 
HCPs (>80%) reported limited knowledge about the role of CTs in cancer care or evidence to support CT use. Questions 
about communication and interactions revealed that 80% of patients reported not having had an HCP speak to them 
about CTs. However, 63% of HCPs reported addressing CT use. Conclusion. Results demonstrate a need for improved CT 
education and training for patients and HCPs. increasing HCP knowledge and clinical skills will ensure patients’ information 
needs about CTs are acknowledged and attended to, thereby providing safer and comprehensive cancer care.
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addition to standard treatment, whereas alternative therapies 
are used instead of conventional medicine.6
A recent meta-analysis found that 45% of all cancer 
patients worldwide have used CAM since their diagnoses.5 
CAM is most popular with females, breast cancer patients, 
younger individuals, and those with a higher level of educa-
tion and higher socioeconomic status.7-9
Despite the high use of CAM by cancer patients and a 
preference to receive CAM information from credible 
sources,10 patients list support groups, friends, family, and 
books as their primary sources of CAM information.11,12 
This presents a problem as patients may be receiving unreli-
able information and are often overwhelmed and confused 
about the credibility of CAM information available.10 
Additionally, it has been reported that up to 77% of cancer 
patients do not disclose their CAM use to their HCP, dem-
onstrating a lack of patient–practitioner communication 
about CAM.13 This lack of communication is concerning 
given the potential for CAM to exacerbate or alleviate 
symptoms related to conventional treatments, as well as the 
risk of interaction with conventional medications.14
HCPs have a responsibility to provide optimal care for 
their patients and this should include addressing the risks 
and benefits of CAM. Indeed, many patients assume that 
HCPs will do so.10 However, this is not occurring in prac-
tice, possibly because many HCPs are unaware that CAM is 
within their scope of practice, are uncertain of CAM evi-
dence, lack training about CAM therapies, or are skeptical 
about CAM use.10,15-18
The goal of this study was to understand why commu-
nication about CAM is not occurring between patients 
and HCPs, and how CAM communication could be 
improved during HCP–patient interactions. Therefore, we 
examined (a) patient preferences, use, and reasons for 
using CT; (b) deficiencies in patients’ access to informa-
tion and information-seeking behavior; (c) HCPs’ knowl-
edge, preparedness, opinions, and beliefs about CAM; 
and (d) patient–HCP interactions, with a focus on com-
munication about CAM.
Methods
Participants
Patients. People diagnosed with any type of cancer, aged 18 
years and older, and who were attending outpatient clinic 
appointments at the Tom Baker Cancer Centre were eligible 
to participate. There were no restrictions on stage of dis-
ease, time since diagnosis, or treatments received.
HCPs. Health care providers of any discipline working at 
the Tom Baker Cancer Centre who had contact with cancer 
patients were eligible to participate. The research was 
approved by the Conjoint Health Research Ethics Board of 
the University of Calgary. Participation was voluntary, and 
it was explained that completion of questionnaires was con-
sidered implied consent.
Procedures
Patients were approached in 2 outpatient clinics in Calgary, 
Alberta. The researchers informed the patients of the pur-
pose of the study, and those that agreed to participate were 
given the option of completing the questionnaire at the 
clinic, or taking a questionnaire home, and returning it 
using a postage-paid envelope. Patients were only asked 
about CTs, not alternative therapies. The focus on CTs was 
used to avoid suggestions that the researchers advocated the 
use of alternative therapies instead of conventional 
medicine.
HCPs were recruited from the main cancer care hospital 
in Calgary, Alberta. The HCP survey asking about CAM 
was distributed via email to all HCPs. To reach as represen-
tative a sample as possible, the survey was also distributed 
at various department meetings by the research team or 
department heads. Hard copies of the survey were distrib-
uted to oncologists’ mailboxes.
Questions: Patients
Use of CTs. Patients were asked whether they had used CTs 
since their cancer diagnosis, and if they had used CTs, 
which type(s) based on the NCCIH categories. These ques-
tions were adapted from a patient needs assessment survey 
designed and used within the University of British Colum-
bia (UBC)/British Columbia Cancer Agency (BCCA) Com-
plementary Medicine Education and Outcomes Program 
(CAMEO).19 Permission for the use and modification of the 
CAMEO survey was obtained.
Interest in CTs. Patients were asked to rate their interest in 
learning more about each type of CT on a 5-point Likert-
type scale. This question was created in order to determine 
relative interest in the various categories of CTs.
Reasons for Using CTs. Patients were asked to check all rea-
sons for their use of CTs. The options were predefined and 
adapted from previous research examining CAM use in 
cancer patients.12,20 Patients were also asked to indicate the 
single, primary reason for their use of CTs.
Barriers to Using CTs. Eight items comprising established 
barriers to CT use reported during focus groups in the 
United Kingdom,21 and other barriers the researchers 
hypothesized would affect patient use of CTs were pre-
sented within the questionnaire. Using a 5-point Likert-type 
scale patients indicated the extent to which they found each 
potential item a barrier to their use of CTs.
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CT Information Needs. Patients were asked whether they 
had needed information on any of 8 listed questions about 
CTs since their cancer diagnosis. These questions were rep-
licated from the UBC/BCCA CAMEO survey.19 Further-
more, patients were asked whether they would use an 
in-house hospital-based CT education program if one were 
available.
Patient Perceptions of HCP Relationship. Patients were pro-
vided with 9 questions, again drawn from the UBC/BCCA 
CAMEO survey,19 asking about patient–practitioner CT 
communication. First, patients were asked if any HCP had 
spoken to them about CTs. If patients had been spoken to 
about CTs, they were asked to identify the specific HCP 
who had spoken to them. The remaining 7 questions uti-
lized a 3-point Likert-type scale to examine information 
seeking, decision making, comfort, and satisfaction in rela-
tion to CT communication with the HCP.
Questions: HCPs
Knowledge About CAM. Eight questions were used to assess 
knowledge of CAM and its role in cancer care. These ques-
tions came from a HCP practices and learning needs survey 
designed and utilized by the UBC/BCCA CAMEO 
program.19 The term CAM was used in the provider ques-
tionnaires to replicate the original instrument.19
Preparedness for CAM. Practitioners were required to rate 
their CAM clinical and information seeking skills prepared-
ness on a 4-point Likert-type scale for 10 items. Six ques-
tions assessed clinical skills whereas 4 assessed preparedness 
to find credible information about CAM therapies. All ques-
tions were drawn from the UBC/BCCA CAMEO HCP 
survey.19
Opinions and Beliefs About CAM. Opinions and beliefs about 
CAM were obtained through 6 questions using a 5-point 
Likert-type scale. The questions were adapted from a sur-
vey conducted by Visser and Peters22 on the attitudes of 
Turkish general practitioners (GPs) toward alternative med-
icine. The questions have high internal consistency (Cron-
bach’s α = .86)22 and have been previously used to assess 
the opinions of Canadian GPs toward alternative 
medicine.23 The wording of the questions were altered from 
the original22 and replaced the term “alternative medicine” 
with the term “CAM.”
Perceptions About Patient Relationship and CAM. The ques-
tionnaire contained 25 questions addressing HCPs’ current 
practice in the previous month. Six questions asked HCPs 
about how patients were interacting with them. The follow-
ing 13 questions addressed HCP interactions with patients. 
Two questions asked HCP if they had directed patients to 
consult with another HCP to have their questions answered 
or information needs met. The next 2 questions asked HCPs 
to report if they had consulted with other HCPs in order to 
answer patient questions. The final 2 questions in this sec-
tion asked HCPs whether they had referred patients to web-
sites for CAM information, and to which website(s) they 
referred patients. All questions were derived from the UBC/
BCCA CAMEO HCP survey.19
Interest in Further Education. HCPs were asked to indicate, 
on a 5-point Likert-type scale, their interest in receiving 
more information, education, and/or training about CAM.
Data Analysis
Data were analyzed using descriptive statistics and frequen-
cies to explain the outcomes for the 2 participant groups. 
Chi-squares analysis, using SPSS v21.0, examined relation-
ships between the prevalence of various categorical vari-
ables and demographic data. Power calculations revealed a 
sample size of 599 patients would provide a confidence 
level of 99%, with a 5-point margin of error. A sample of 
170 HCPs, out of a total population of 300, would achieve a 
95% confidence level with a 5-point margin of error.
Results
Demographics
Patients. Approximately 800 cancer outpatients were 
approached to participate. A total of 481 patients completed 
the surveys, resulting in approximately 60% response rates. 
Therefore, the final sample size is marginally underpow-
ered, resulting in a 95% confidence interval with a 5-point 
margin of error for patients. The complete demographics of 
the patients are reported in Table 1. Briefly, the mean age of 
the patients was 59 years, 62% were female, 78% Cauca-
sian, diagnosed with a variety of cancer types.
HCPs. Approximately 300 HCPs were approached to par-
ticipate and 100 completed the surveys, resulting in a 30% 
response rate. Therefore, the final sample size is marginally 
underpowered, resulting in a 95% confidence interval with 
an 8-point margin of error for HCPs. The complete demo-
graphics of the HCPs are reported in Table 2.
Patients’ Use, Interest, Reasons for Use, and 
Barriers to Use of CTs
Almost half of all patients surveyed (47.2%, n = 227) 
reported using CTs since being diagnosed with cancer. 
Biologically based therapies (74.9%, n = 170) were most 
commonly used. Mind–body therapies were used by 48.5% 
(n = 110) of CT-using patients, followed by energy-based 
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Table 2. Demographic Characteristics of Health Care 
Practitioners (HCPs; n = 100).
n %a
Gender  
 Female 51 51.0
 Male 20 20.0
Age  
 18-34 19 19.0
 35-49 26 26.0
 50-64 25 25.0
 65+ 1 1.0
Type of HCP  
 Nurse 20 20.0
 Medical oncologist 8 8.0
 Gynecological oncologist 8 8.0
 Pharmacist 7 7.0
 Social worker 4 4.0
 Psychologist/psychiatrist 4 4.0
 Radiation oncologist 3 3.0
 Surgical oncologist 2 2.0
 Clinical associate 1 1.0
 Dietitian 1 1.0
 Radiation therapist 1 1.0
 Unit clerk/administrative support 1 1.0
 Other 29 29.0
Main area of practice  
 Clinical practice 64 91.4
 Education 20 28.6
 Research 16 22.9
 Administration 6 8.6
 Other 2 2.9
Primary cancer site  
 Various 28 40.0
 Breast 23 32.9
 Prostate 21 30.0
 Lung 21 30.0
 Gynecological 21 30.0
 Head and neck 19 27.1
 Blood 18 25.7
 Gastrointestinal 17 24.3
 Genitourinary 17 24.3
 Colorectal 15 21.4
 Skin 14 20.0
 Central nervous system 13 18.6
 Other 10 14.3
aValue accounts for missing data.
CTs (34.4%, n = 78), manipulative and body-based CTs 
(31.7%, n = 72), and lastly whole medical system use 
(14.1%, n = 32). Fifty-three participants (23%) also reported 
using other forms of CT, such as cleansing programs and 
following special diets.
Significantly more females, χ2(1) = 7.1, P = .009, 
younger individuals (≤58 years old), χ2(1) = 5.9, P = .016, 
those with more education, χ2(6) = 21.3, P = .002, and those 
who were diagnosed over a year prior to the survey, χ2(2) = 
15.8, P < .001, reported utilizing CTs.
Approximately 65% of patients expressed an interest in 
learning more about at least one CT. Interest was spread 
across all 5 domains, but was relatively consistent across 
each type (46% to 53%). When including those patients 
who reported being “neither interested nor uninterested,” 
77.2% of patients may desire to learn more about CTs.
Among the 224 participants who indicated their reasons 
for using CTs, the 4 most prevalent reasons were the follow-
ing: to improve quality of life (QOL; 64.7%, n = 145), to 
Table 1. Demographic Characteristics of Patients (n = 481).
n %a
Gender  
 Female 278 57.8
 Male 170 35.3
Ageb  
 58 or below 205 42.6
 59 or above 228 47.4
Marital status  
 Single 47 9.8
 Married 298 62.0
 Common law 32 6.7
 Separated 8 1.7
 Divorced 28 5.8
 Widowed 32 6.7
Education  
 Less than high school 35 7.3
 High school graduate 83 17.3
 College or technical school 156 32.4
 Bachelor’s degree 87 18.1
 Higher degree 82 17.1
Ethnicity  
 Caucasian 376 78.2
 Asian 41 8.5
 Aboriginal 10 2.0
 Arab 2 0.4
 Black/African American 2 0.4
 Other 10 2.1
Cancer diagnoses  
 Breast 97 20.2
 Gynecological 69 14.3
 Colorectal 49 10.2
 Brain 30 6.2
 Prostate 29 6.0
 Skin 29 6.0
 Lymphoma/leukemia 28 5.8
 Gastrointestinal 20 4.2
 Lung 11 2.3
 Other 49 10.2
aValue accounts for missing data.
bMedian age = 58 years; data recoded and split at 58.
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improve immune system (54.3%, n = 121), to treat/be good 
to myself (40.8%, n = 91), and to increase feelings of hope 
(35.1%, n = 78). Relieving either cancer-related or treat-
ment-related fatigue was the most common symptom for 
which CT was used, reported by approximately 24% of all 
patients. Forty-eight patients (21.6%) also reported that 
they were using CT to cure their cancer.
The primary reason for commencing CT use was 
answered by 166 patients. Most (43.4%, n = 72) revealed 
that their CT use was motivated by recommendations from 
family and/or friends. When questioned about their barriers 
to CT use, the majority of patients reported being unsure 
about the quality of evidence supporting CTs (71%, n = 
245/345) and a lack of knowledge about CTs (68.6%, n = 
243/354) to be barriers to their use of CTs.
Patient CT Information Needs
The most common questions about CTs were the following: 
(a) What complementary therapies can be used safely in 
combination with medical cancer treatments? (36.4%, n = 
175); (b) What complementary therapies are helpful for 
people with cancer? (35.6%, n = 171); (c) When is it safe to 
use complementary therapies after being diagnosed with 
cancer? (32.6%, n = 157); and (d) Where do I find trustwor-
thy information about complementary therapies? (32.4%, 
n = 156). In response to whether or not they would use an 
in-house, hospital-based CT education program, 281 of 387 
(72.6%, 58.4% of the total sample) reported that they would 
use such a program.
HCPs’ Current Knowledge, Preparedness, and 
Opinions and Beliefs About CAM
CAM knowledge of HCPs was very limited. Between 20% 
and 40% reported having no knowledge in 7 of the 8 mea-
sures reported in Table 3. The majority of HCPs reported 
being only somewhat knowledgeable or not at all knowl-
edgeable about various aspects and roles of CAM, and 
almost none professed to be very knowledgeable.
The majority of HCPs reported being only somewhat or 
not at all prepared when asked about CAM clinical and 
information seeking skills (see Table 4). Almost 70% of 
HCPs felt not at all prepared to monitor cancer patients’ 
CAM use and fewer than 9% of HCPs reported being very 
capable of searching for credible evidence-based informa-
tion on CAM and cancer.
Mixed results were also found when examining the 
beliefs and opinions of HCPs toward CAM (Table 5). For 
example, 49.9% (n = 36) agreed that CAM is a useful sup-
plement to regular medicine, whereas almost 21% (n = 15) 
disagreed. The most widely agreed view (66.6%, n = 48) 
was that CAM includes ideas and methods from which con-
ventional medicine could benefit.
Patient–Practitioner Relationship and 
Communication About CAM
The vast majority of patients (79.7%, n = 374) reported that 
no HCP had spoken to them about CTs. Of those patients 
who indicated they did speak to a HCP, most often this was 
with either medical oncologists (40.2%, n = 43) or nurses 
(40.2%, n = 43). In spite of so few patients engaging in CT 
communication, more than 70% (n = 295) reported that they 
were comfortable talking to their HCPs about CTs, but only 
28.8% (n = 99) of patients agreed that their HCP had lis-
tened to what they had to say. Overall, only 55 (16%) 
patients felt that they had received enough information 
about CTs from cancer health care professionals (Table 6).
A significant relationship was found between informa-
tion and support-seeking and the information and support 
received. Significantly more patients who requested CT 
information from their HCPs felt that they received enough 
CT information, χ2(4) = 139.2, P < .01, and that they 
received enough support in making decisions about CTs, 
χ2(4) = 73.1, P < .01. Similarly, significantly more patients 
who requested CT decision-making support from their 
HCPs felt that they had received enough CT information, 
χ2(4) = 139.2.1, P < .01, and that they had received enough 
support in making decisions about using CTs, χ2(4) = 157.1, 
Table 3. Health Care Practitioners’ Complementary and Alternative Medicine (CAM) Knowledge Level.
Not at All 
Knowledgeable
Somewhat 
Knowledgeable Knowledgeable
Very 
Knowledgeable
 n % n % n % n %
Role of CAM in cancer prevention 23 31.1 39 52.7 10 13.5 2 2.7
Role of CAM in cancer treatment 24 32.4 37 50.0 13 17.6 0 0
Role of CAM in cancer symptom management 17 23.0 43 58.1 14 18.9 0 0
Role of CAM in cancer survivorship 29 39.2 35 47.3 10 13.5 0 0
Evidence to support use of CAM 23 31.1 37 50.0 13 17.6 1 1.4
Risks and benefits of CAM 20 27.0 40 54.1 14 18.9 0 0
Underlying principles, theory, and beliefs of CAM 22 29.7 40 54.1 10 13.5 2 2.7
Why patients use CAM 12 16.2 34 45.9 21 28.4 7 9.5
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P < .01. In addition, significantly more of those patients 
who felt their HCP listened to them about CTs were com-
fortable in discussing CTs, χ2(4) = 88.2, P < .01, requested 
information about CTs, χ2(4) = 498, P < .01, and felt that 
they had received enough CT information, χ2(4) = 82.3, P < 
.01, and CT decision-making support, χ2(4) = 75.5, P < .01.
HCP Perceptions
To complement patient reports, HCPs were asked how 
patients were interacting with them about CAM. Just over 
70% (n = 61) of HCPs indicated that at least one patient had 
told them about CAM use in the past month. On average, 
Table 4. Health Care Practitioners’ (HCPs’) Levels of Preparedness Regarding Complementary and Alternative Medicine (CAM) 
Clinical Skills and CAM Information Seeking.
Not at All 
Prepared
Somewhat 
Prepared Prepared
Very 
Prepared
 n % n % n % n %
Clinical skills
 Assess patients’ use of CAM 27 37.0 31 42.5 12 16.4 3 4.1
 Assist patients in disclosing CAM use to HCPs 23 31.9 30 41.7 14 19.4 5 6.9
 Assist patients in making decisions about CAM 25 34.2 36 49.3 10 13.7 2 2.7
 Talk to patients who want to use CAM instead of conventional treatment 29 39.7 30 41.1 10 13.7 4 5.5
 Respond to patient requests for specific CAM recommendations 31 42.5 30 41.1 11 15.1 1 1.4
 Monitor cancer patients’ use of CAM 50 68.5 21 28.8 1 1.4 1 1.4
Information seeking skills
 Find credible CAM information resources 20 27.8 36 50.0 12 16.7 4 5.6
 Identify the credibility of CAM information resources 28 38.9 28 38.9 12 16.7 4 5.6
 Search for evidence about CAM 21 29.2 30 41.7 15 20.8 6 8.3
 Critique evidence about CAM 22 30.6 30 41.7 15 20.8 5 6.9
Table 5. Health Care Practitioner Endorsement of Opinions and Beliefs About Complementary and Alternative Medicine (CAM).
Strongly 
Disagree Disagree
Neither Agree 
nor Disagree Agree
Strongly 
Agree
 n % n % n % n % n %
CAM is a threat to public health 22 30.6 21 29.2 25 34.7 3 4.2 1 1.4
Treatments not tested scientifically should be discouraged 7 9.7 8 11.1 28 38.9 24 33.3 5 6.9
CAM is a useful supplement to regular medicine 2 2.8 13 18.1 21 29.2 25 34.7 11 15.2
Results from CAM are usually due to a placebo effect 8 11.1 23 31.9 30 41.7 9 12.5 2 2.8
Most CAM stimulates the body’s natural therapeutic powers 7 9.7 12 16.7 33 45.8 12 16.7 8 11.1
CAM includes ideas and methods from which conventional 
medicine could benefit
3 4.2 3 4.2 18 25.0 33 45.8 15 20.8
Table 6. Patient Perceptions of Communication With Health Care Practitioners (HCPs).
Agree
Neither Agree nor 
Disagree Disagree
 n % n % n %
I am comfortable talking to HCPs about complementary therapies (CTs) 295 70.9 80 19.2 41 9.9
HCPs listened to what I had to say about CTs 99 28.8 206 42.8 39 11.3
I requested information about CTs 46 12.7 167 46.0 46 12.7
HCP connected me with someone who provided CT information 39 11.3 146 42.2 161 46.5
I received enough information about CTs 55 15.9 141 40.9 149 43.2
I requested support in making decisions about CTs 48 14.2 135 40.1 154 45.7
I received enough support in making decisions about CTs 49 14.4 172 50.4 120 35.2
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HCPs reported that roughly 1 in every 5 (23.3%) patients 
was telling them about CAM use. Moreover, 50 (58.1%) 
HCPs reported a similar ratio (21.1%) of patients seeking 
advice about a CAM therapy that they were currently using. 
It was less common for HCPs to be asked to monitor patient 
use of a CAM therapy (12.3%, n = 11), or refer patients to a 
CAM service or CAM practitioner (15.1%, n = 13).
HCPs were also asked about how they were interacting 
with patients about CAM. Close to 63% (n = 50) of HCPs 
reported asking patients about their use of CAM. Nearly 
half (45%, n = 36) of HCPs provided patients with recom-
mendations about a CAM therapy, while only 8.8% (n = 7) 
of HCPs were monitoring a patient’s use of CAM and even 
fewer (6.3%, n = 5) were providing a CAM therapy to 
patients. Close to a third (32.5%, n = 26) of HCPs reviewed 
CAM evidence with patients and 25.0% (n = 20) provided 
patients with CAM educational materials. Very few HCPs 
(11.5%, n = 9) referred patients to websites for CAM infor-
mation. A greater proportion of HCPs (49.5%, n = 39) had 
suggested a patient discontinue a CAM therapy than had 
suggested a patient use a CAM therapy (32.9%, n = 26).
Of those HCPs who had suggested a patient discontinue 
a CAM therapy, antioxidants (especially when on radiation 
therapy), herbs, and high-dose vitamins were the therapies 
most often advised against. The main reasons practitioners 
suggested CAM therapy discontinuation included theoreti-
cal concerns of interaction (92.3%, n = 36), literature evi-
dence of interaction/harm (46.2%, n = 18), no evidence of 
efficacy (43.6%, n = 17), and personal clinical experience 
of interaction/harm (12.8%, n = 5).
HCPs who suggested patients use a CAM therapy most 
often suggested mind–body therapies and acupuncture. 
Practitioners based these suggestions mainly on positive 
effects seen in other patients (73.1%, n = 19), literature evi-
dence of benefit (65.4%, n = 17), and personal clinical 
experience of benefit (57.7%, n = 15).
By their own admission, most HCPs believed that they 
required further education and/or training about CAM for 
cancer care. When surveyed, 90% (n = 63) reported being 
interested (44.3%, n = 31) or very interested (45.7%, n = 
32) in receiving additional CAM training. Only 31.4% (n = 
22) of HCPs reported having already received some CAM 
training, predominantly in the form of conference presenta-
tions, through a hospital in-service program, and from sem-
inars/lectures in medical school.
Discussion
This study explored patients’ use, interest, and information-
seeking behavior around CTs as well as HCPs’ knowledge, 
opinions, and beliefs and revealed some interesting discrep-
ancies between the perceptions of patients and those of their 
HCPs. For example, many patients reported that HCPs did 
not discuss CT use with them, but a greater proportion of 
HCPs felt they had. Other unique findings discussed below 
explore communication between patients and HCPs, patient 
needs for information and decision support, as well as train-
ing needs of HCPs.
Patients’ Use, Interest in Use, Reasons for Use, 
and Barriers to Use of CTs
Similar to previous reports,5 47.2% of patients reported using 
CTs since cancer diagnosis, biologically based and mind–
body therapies were most popular, and CT use was higher 
among females, younger individuals, and those with greater 
education.7-9 Individuals who were at least 12 months post 
diagnosis were more likely to report using CTs. This finding 
suggests that CT use changes over the cancer trajectory, 
which supports previous findings that identify the influence 
of disease status as well as psychological social, cultural, and 
other factors, such as patient–provider communication on CT 
use.10,24,25 At the time of diagnosis, many patients are interested 
in taking stock of the full range of conventional and CT treat-
ment options, requiring open, unbiased, and purposeful com-
munication about CTs and CT decision support by HCPs. 
Complementary therapy decisions and use has been shown to 
shift over the cancer trajectory, particularly at times of transi-
tion, such as at the end of primary treatment, or when disease, 
social, or other contextual factors shift.10 These transition are 
also key points for interaction and communication with HCPs 
about CTs to ensure patients’ CT information and decision 
support needs are met.26
Consistent with previous research, the most common 
reason patients reported using CTs was to improve their 
quality of life.12,20,27 Research also suggests that patients use 
CAM for other beneficial effects and to play an active role 
in their treatment,9,10 which was echoed in the present study. 
Patients were using CTs as a form of symptom manage-
ment, to reduce cancer and treatment-related fatigue and to 
improve their immune system. CT use was also employed 
as a means of improving emotional well-being with patients 
reporting CT use to be good to themselves or to improve 
feelings of hope.
Surprisingly, just over 1 in 5 patients indicated using CTs 
to cure their cancer. This underscores the need for greater 
patient education about CTs to reduce misperceptions and 
reinforce the necessity of using CTs as an adjunct to con-
ventional medicine, not as an alternative.
When asked about their primary reason for initiating CT 
use, most patients reported that they began due to recom-
mendations from family or friends. This finding replicates 
previous research, as did the finding that few patients began 
using CTs due to HCP recommendation.11,12 Though family 
and friends are well intentioned, it is concerning that they 
are the primary motivators for uptake of CT as the informa-
tion provided may be inaccurate or not account for potential 
adverse effects the CT could present to the patient. This 
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finding is surprising since the largest barriers to CT use 
were either being unsure about the quality of evidence sup-
porting CTs and a lack of knowledge about CTs. The lack of 
HCP-initiated communication about CTs (80% of patients 
reported no HCP had asked them about CT use) may deter 
patients raising this subject further. However, it is also pos-
sible that patients choose not to tell their HCPs about their 
CT use, thus eliminating any role, be it positive or negative, 
that their HCP may have in their use of CTs. Despite con-
cerns about the impact CTs may have on their health and 
wanting to be informed about safety and effectiveness of 
CTs, patients do not appear to be sufficiently engaged with 
HCPs. Therefore, the availability of evidence-based patient 
resources to increase patients’ knowledge of CTs would 
likely enable patients to be better prepared to make informed 
decisions about using CTs.
HCPs’ Knowledge, Preparedness, Opinions and 
Beliefs, and Interest in Further Education About 
CAM
Congruent with previous studies,15,16,28 HCPs reported little 
knowledge about CAM. Similarly, HCPs felt relatively 
unprepared to address CAM in a clinical context, or to find 
and evaluate information about CAM. These findings are 
concerning as patients either already are or should be turn-
ing to their HCPs for advice and guidance about compre-
hensive cancer care, including CAM. A lack of knowledge 
about CAM limits a HCP’s ability to provide patients with 
accurate and supportive advice. Moreover, if practitioners 
are not prepared to assess and monitor CAM use, or provide 
specific CAM recommendations and guidance, this is likely 
to negatively affect the patient–practitioner relationship and 
cancer-related outcomes. Previous research has demon-
strated that when HCPs do not engage patients or are per-
ceived as unwilling or unprepared to discuss CAM, this can 
impair the overall patient–HCP relationship.18,26 This lack 
of communication about CAM may place patients in a situ-
ation where they are required to independently make CAM 
decisions as well as self-monitor their CAM use. Lack of 
guidance and support for HCPs about CAM may lead to 
unintended patient self-harm and/or interfere with expected 
conventional treatment outcomes.26
Also concerning was that many HCPs reported being 
unprepared to evaluate whether information was credible or 
suitable for their patients (Table 4). In general, HCPs have 
training in information seeking and evaluation, so this result 
may be related to the complexities and unfamiliarity of 
CAM literature for these professionals. Only a third of 
HCPs reported having received any CAM training; this lack 
of training may explain practitioners’ deficiencies in CAM 
knowledge and preparedness, highlighting the need for fur-
ther education to improve competencies in these areas.
HCPs acknowledged the need to learn more about CAM. 
It was found that 90% of practitioners reported interest in 
receiving further CAM education. This interest is consistent 
with practitioners’ efforts to address CAM needs for patients 
reported by others.15,16 Furthermore, it is known that 
increasing CAM training leads to an increase in CAM rec-
ommendations, improves patient–practitioner communica-
tion about CAM, and creates more positive and open 
attitudes toward CAM.29
Patient–Practitioner Perceptions and 
Communication
Patients and HCPs were asked several questions about the 
type and quality of communication that was occurring. The 
findings in this area were generally not consistent, and did 
not always reflect positively on the overall relationship. It is 
possible that HCPs and patients hold different perceptions 
of what “speaking to” and “being spoken to” about CTs 
consists of. Patients may be expecting a more in depth dis-
cussion of CTs than HCPs are offering, or the timing of the 
discussions initiated by HCPs may not align with when 
patients are most receptive to hearing or engaging in them. 
The discrepancy may also be explained by the large propor-
tion of patients who were diagnosed with cancer for a year 
or less. As reported above, patients in this study were more 
likely to use CTs with increasing time since diagnosis and, 
therefore, the practitioners may have been more focused on 
conventional and curative treatment and not yet have had a 
chance to speak to patients in the early stages of their cancer 
care journey about CTs.
A notable discrepancy existed between HCPs’ reports of 
their current practice around CTs and patients’ reports of 
communication about CTs. The findings from the patients 
in this study suggested that HCPs are not adequately 
addressing their needs or providing sufficient information 
and support about CTs. In contrast, two thirds of practitio-
ners reported asking patients about their use of CAM, which 
could provide a doorway for further discussion. The differ-
ence in results between patients and practitioners may be 
explained by the sample of HCPs being examined. The 
HCPs who responded to this questionnaire may have been 
more interested in CTs and thus a more involved and 
informed subsample of practitioners.
Nonetheless, it is apparent that the majority of patients 
are not discussing CTs with their HCPs, even though 
patients are willing to discuss their CAM use and are turn-
ing to their practitioners for advice and guidance. Patients 
trust their HCPs21 and want them to play a role in determin-
ing how and when CAM therapies are used. Patients expect 
that HCPs will initiate discussions of CTs10 and have cited 
in the past “not being asked about CTs” as a reason for non-
disclosure of their use.27 The lack of HCP-initiated CT 
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discussions is concerning for a number of reasons, particu-
larly the potential for negative impact on patient health.
HCP results suggested that patients are increasingly ini-
tiating discussions of CTs. Over two thirds of HCPs indi-
cated that a patient had told them about their CAM use. This 
is a positive finding as patient disclosure of CAM use has 
been associated with patient-centered communication, 
which in turn has been shown to enhance satisfaction with 
care, reduce distress, and improve conventional treatment 
adherence.26,30,31 On average, a quarter of the patients seen 
by practitioners were reporting their CAM use to HCPs; a 
similar proportion has been reported in previous studies.32 
This figure reveals that three quarters of patients are not 
self-disclosing their use of CAM to their practitioners, once 
again highlighting the need for HCPs to initiate CAM 
discussions.
In contrast, almost half of the HCPs indicated that they 
provided recommendations about CAM to their patients. 
Practitioners suggested more often that patients discon-
tinue, as opposed to commence CAM. Initiating CAM was 
only suggested on the basis of research evidence or personal 
clinical experience displaying beneficial effects. However, 
almost all practitioners reported that they would suggest 
discontinuing CAM based on theoretical concerns about 
interactions with conventional medicine. This was often 
supplemented with evidence of harmful interactions or lack 
of efficacy. In general, HCPs required a higher standard of 
proof to recommend CT than they needed to remove it. This 
practice ensures patient safety and is complimented by 
research demonstrating that HCPs are not willing to recom-
mend CAM that is not backed by scientific evidence.15
Limitations
Some limitations should be considered when interpreting 
the findings of this study. The response rate of 30% for 
HCPs limits the generalizability of these findings, and 
raises questions about whether the overall positive view of 
CAM is a true representation or if self-selection bias 
affected the opinions and beliefs of HCPs. This bias may 
have led to practitioners who hold more positive views of 
CAM to participate. Reasons for nonparticipation were not 
recorded and, therefore, it is not possible to determine 
whether HCPs withdrew due to a lack of interest or knowl-
edge of CTs.
The response rate of 60% was far greater for the patients; 
however, the generalizability of the results is also affected 
by the fact that a large proportion of patients were diag-
nosed less than 12 months previously. Therefore, findings 
may not be applicable to individuals with more chronic can-
cers or long-term cancer survivors.
A final limitation of the study, faced by all research in 
this area, is the broad definition of CAM and the large 
number of therapies it encompasses. Both the patient and 
HCP questionnaires addressed this issue by using stan-
dardized definitions. The patient questionnaire further 
addressed the issue by using examples of CTs and asking 
patients about CTs in general, the 5 categories of CTs, and 
to list the specific CTs they utilized. The HCP question-
naire was less successful at addressing the variety of ther-
apies and products encompassed by CAM as it only asked 
about CAM as a whole. Several HCPs commented that 
their practice, knowledge, skills, opinions, and beliefs 
varied based on the CAM therapy or product being 
discussed.
Conclusions
In summary, almost half of the cancer patients surveyed had 
utilized CTs since their diagnosis. Patients report that HCPs 
are not communicating with them about CTs and that their 
CT information and decision-making needs are not being 
met. However, when communication occurs, it appears to 
be effective in satisfying patient concerns. Patients are 
interested in learning more about CTs, specifically the 
impact on their health, and would utilize a hospital-based 
education program to obtain this knowledge. In contrast, 
HCPs reported a greater incidence of patient-initiated com-
munication about CAM and also report more practitioner-
initiated communication than patients did. HCPs are 
cautious in the recommendations they make about CAM, 
making more recommendations toward discontinuation of 
CAM. Similar to patients, HCPs were interested and willing 
to receive more education and training in CAM.
There is a clear need for improved education and train-
ing materials and programs for both patients and HCPs. 
Such materials and training will help ensure HCPs are 
meeting patients’ CT needs. It will also help guarantee that 
patients are receiving reliable and accurate information 
about CTs and guidance that will allow for CTs to be used 
to improve their health and well-being, while avoiding the 
potentially harmful impact of inappropriate CT use. Finally, 
increased education and training about CTs will move can-
cer care toward providing a more integrative form of oncol-
ogy that will allow patients to have all of their care and 
information needs to be met at a single location.
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